| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-10 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-09 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-07 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |